DROXIA 6335 DROXIA 6335
Generic Name: hydroxyurea
Pill imprint DROXIA 6335 DROXIA 6335 has been identified as Droxia 200 mg.
Droxia is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy.
Droxia 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Droxia Images
- Generic Name:
- hydroxyurea
- Imprint:
-
DROXIA 6335
DROXIA 6335 - Strength:
- 200 mg
- Color:
- Green
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- citric acid
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-6335
Advertisement
More Droxia resources
Search Again
